首页|期刊导航|癌症生物学与医学（英文版）|First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients

First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients

Chuanhua Zhao Sisi Ye Meng Chen Jing Qian Jianming Xu

癌症生物学与医学（英文版）2026，Vol.23Issue(2)：201-217,17.

癌症生物学与医学（英文版）2026，Vol.23Issue(2)：201-217,17.DOI:10.20892/j.issn.2095-3941.2025.0398

First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients

Chuanhua Zhao ¹Sisi Ye ¹Meng Chen ²Jing Qian ²Jianming Xu¹

作者信息

1. The Fifth Medical Center,Chinese PLA General Hospital,Beijing 100071,China
2. Value&Implementation,MSD China,Shanghai 200030,China
折叠

摘要

关键词

Asia/gastric cancer/HER2-negative/immunotherapy

Key words

Asia/gastric cancer/HER2-negative/immunotherapy

引用本文复制引用

Chuanhua Zhao,Sisi Ye,Meng Chen,Jing Qian,Jianming Xu..First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients[J].癌症生物学与医学（英文版）,2026,23(2):201-217,17.

基金项目

This manuscript was funded by MSD China.This work was supported by grants from Non-communicable Chronic Diseases-National Science and Technology Major Project(Grant No.2024ZD0520600). （Grant No.2024ZD0520600）

癌症生物学与医学（英文版）

ISSN：2095-3941

访问量0

下载量0

段落导航